Article
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
2018-12-14
Abstract excerpt
<h4>Background</h4> Triple-negative breast cancers are poor-prognosis tumors characterized by absence of molecular signature and are chemotherapy is still the only systemic treatment. Currently, research focus to identify biomarkers that may be usable for prognosis and/or for treatment, notably among the proteins involved in cell migration and metastatic capacity. <h4>Methods</h4> We used proteomic approach to i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b6b2b24c-7d62-5a7f-b8e9-9b388cb76500
- DOI
- 10.1101/496026
